Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
SNAP benefits are set to run out on Saturday. Far-right influencers and extremists are incorrectly claiming that immigrants ...
Assisted Reproductive Technology (ART) has advanced rapidly, yet challenges in selecting the most viable embryos for transfer persist. Historically, embryo ...
If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation. When ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
This month, President Donald Trump released new federal guidance encouraging private employers to include fertility ...
23h
Ohio anti-abortion advocates support Baby Olivia Act; lawmakers question showing it to third graders
Doctors, anti-abortion advocates, and a mother spoke in favor of a bill that would require Ohio public schools to show a ...
Inherited diseases should not dictate human fate. Today, with advances in genomics, a different future is within reach. In this new era of genomic medicine, Manhattan Genomics, led by serial biotech ...
News-Medical.Net on MSN
New method yields up to twice as many therapeutic myogenic cells as previous protocols
If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation.
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
A large clinical trial shows stem cell therapy can help repair heart tissue and improve recovery in patients after a heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback